Colton Groome Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
4,494
-1,615
-26% -$553K 0.39% 48
2026
Q1
$2.15M Buy
6,109
+528
+9% +$188K 0.61% 35
2025
Q4
$1.83M Buy
5,581
+160
+3% +$50.8K 0.52% 38
2025
Q3
$1.53M Buy
5,421
+200
+4% +$58K 0.47% 42
2025
Q2
$1.46M Buy
5,221
+943
+22% +$267K 0.49% 41
2025
Q1
$1.24M Buy
4,278
+25
+0.6% +$7.38K 0.48% 39
2024
Q4
$1.11M Sell
4,253
-2,491
-37% -$739K 0.42% 44
2024
Q3
$2.17M Buy
6,744
+350
+5% +$114K 0.81% 29
2024
Q2
$2M Buy
6,394
+5,546
+654% +$1.63M 0.79% 31
2024
Q1
$241K Buy
848
+33
+4% +$9.66K 0.1% 105
2023
Q4
$235K Hold
815
0.1% 110
2023
Q3
$219K Buy
+815
New +$203K 0.11% 105
2023
Q2
Sell
-890
Closed -$215K 119
2023
Q1
$215K Buy
890
+63
+8% +$15.5K 0.1% 115
2022
Q4
$217K Buy
+827
New +$222K 0.11% 118
2022
Q3
Sell
-849
Closed -$207K 115
2022
Q2
$207K Hold
849
0.1% 106
2022
Q1
$205K Buy
+849
New +$195K 0.09% 105

Other funds holding AMGN

Colton Groome Financial Advisors's AMGN Position: Q2 2026 in Review

Colton Groome Financial Advisors reduced its Amgen (AMGN) stake by 26% in Q2 2026, selling an estimated $553K and leaving 4,494 shares worth $1.63M. The position accounts for 0.39% of the portfolio, ranked #48.

Colton Groome Financial Advisors first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.17M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Colton Groome Financial Advisors held 4,494 shares of Amgen worth $1.63M as of Q2 2026.
  • Colton Groome Financial Advisors sold 1,615 Amgen shares in Q2 2026, an estimated $553K.
  • Amgen made up 0.39% of Colton Groome Financial Advisors's portfolio in Q2 2026, its #48 holding.
  • Colton Groome Financial Advisors first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
  • Colton Groome Financial Advisors's Amgen position peaked at $2.17M in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Colton Groome Financial Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.